-
-
-
-
-
-
-
Citi downgrades Moderna to Sell, sets $80 price target
-
-
-
-
-
-
-
Moderna shares gain on momentum and short squeeze
-
-
-
-
-
-
-
FDA approves Moderna's updated 2026-2027 COVID-19 vaccines
-
-
-
-
-
-
-
Moderna stock pulls back after massive one-day rally: analysts weigh in
-
-
-
-
-
-
-
Moderna short sellers face $4.8 billion loss amid record stock jump
-
-
-
-
-
-
-
Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
-
-
-
-
-
-
-
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
-
471,778 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

